CASI PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards
CASI PHARMACEUTICALS, INC. (CASIF) had Deferred Tax Assets, Operating Loss Carryforwards of $54.61 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-15
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $54.61M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $48.55M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $42.54M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $65.46M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $54.61M 20-F · filed 2026-05-15 |
| 2024-12-31 | $48.55M 20-F · filed 2026-05-15 |
| 2023-12-31 | $42.54M 20-F · filed 2025-03-31 |
| 2022-12-31 | $65.46M 20-F · filed 2024-03-28 |
| 2021-12-31 | $69.68M 20-F · filed 2023-04-26 |